526 filings
10-Q
2024 Q1
SNDX
Syndax Pharmaceuticals Inc
Quarterly report
8 May 24
7:04am
8-K
SNDX
Syndax Pharmaceuticals Inc
8 May 24
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
7:03am
ARS
2023 FY
SNDX
Syndax Pharmaceuticals Inc
2 Apr 24
Annual report to shareholders
4:30pm
DEFA14A
SNDX
Syndax Pharmaceuticals Inc
2 Apr 24
Additional proxy soliciting materials
4:02pm
DEF 14A
SNDX
Syndax Pharmaceuticals Inc
Definitive proxy
2 Apr 24
4:00pm
8-K
y9s47 epv
18 Mar 24
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
7:10am
S-3ASR
n60tpo22v3xcrbg2
27 Feb 24
Automatic shelf registration
5:28pm
S-8
hiewz
27 Feb 24
Registration of securities for employees
5:21pm
8-K
0y5k77nfz2mwv5jh
27 Feb 24
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
4:03pm
SC 13G
0uijopa
14 Feb 24
Syndax Pharmaceuticals / Kynam Capital Management ownership change
12:50pm
SC 13G/A
pfim67c mq
14 Feb 24
Syndax Pharmaceuticals / Point72 Asset Management ownership change
7:01am
SC 13G/A
uryju
13 Feb 24
Syndax Pharmaceuticals / Avidity Partners Management ownership change
9:44pm
SC 13G
pb1zbe 0skpju
13 Feb 24
Syndax Pharmaceuticals / VANGUARD ownership change
5:15pm
4
76g9ae3w
9 Feb 24
Syndax Pharmaceuticals / Michael A Metzger ownership change
4:05pm
4
ax08b5zfj 0y
9 Feb 24
Syndax Pharmaceuticals / Keith A. Goldan ownership change
4:05pm
4
g6zr52jb nq
9 Feb 24
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:05pm
4
l5al9k
9 Feb 24
Syndax Pharmaceuticals / Martin H. Jr. Huber ownership change
4:04pm
4
nm4v4
9 Feb 24
Syndax Pharmaceuticals / Jennifer Jarrett ownership change
4:04pm
4
rcxsavgc xuzpo
9 Feb 24
Syndax Pharmaceuticals / Keith Katkin ownership change
4:04pm